Researcher.Life Logo

Journal of Medical Economics : Impact Factor & More

eISSN: 1941-837XpISSN: 1369-6998

Aims and Scope of Journal of Medical Economics

The Journal of Medical Economics is a monthly peer-reviewed academic journal that covers econometric assessments of novel therapeutic and medical device interventions. It is published by Routledge and was established in 1998. The editor-in-chief is K. Lee. Less

Key Metrics

CiteScore
3.7
H-Index
52
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Medical Economics

Journal of Medical Economics Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Medical Economics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Medical Economics

Plain language summary looking at the impact of drug management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the USA
  • 31 Dec 2026
  • Journal of Medical Economics
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison
  • 31 Dec 2026
  • Journal of Medical Economics
CPAP treatment persistence following nasal procedures in obstructive sleep apnea: a real-world claims-based analysis of 1.3 million patients
  • 31 Dec 2026
  • Journal of Medical Economics
Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia
  • 31 Dec 2026
  • Journal of Medical Economics
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
  • 31 Dec 2026
  • Journal of Medical Economics
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis
  • 31 Dec 2026
  • Journal of Medical Economics
Plain language summary looking at the impact of drug management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the USA
  • 31 Dec 2026
  • Journal of Medical Economics
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison
  • 31 Dec 2026
  • Journal of Medical Economics
CPAP treatment persistence following nasal procedures in obstructive sleep apnea: a real-world claims-based analysis of 1.3 million patients
  • 31 Dec 2026
  • Journal of Medical Economics
Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia
  • 31 Dec 2026
  • Journal of Medical Economics
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
  • 31 Dec 2026
  • Journal of Medical Economics
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis
  • 31 Dec 2026
  • Journal of Medical Economics

FAQs on Journal of Medical Economics